Table 3 Current development status of NFκB pathway inhibitors. (Investigational Drugs DataBase, Nov 15 2005 [106], advanced search by activity field on Nuclear factor kappa B inhibitor)
Development status | No. of drugs |
|---|---|
Discovery Research | 22 |
Clinical (unspecified) | 1 |
Phase I clinical trials | 4 |
Phase II clinical trials | 4 |
Phase III clinical trials | 0 |
Pre-registered | 0 |
Registered | 0 |
Launched | 1 bortezomib |
Research tools | 1 |
Suspended | 0 |
Withdrawn | 0 |
No development reported | 4 |
Discontinued | 4 |